California State Teachers Retirement System grew its stake in shares of Maximus, Inc. (NYSE:MMS – Free Report) by 18.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 63,142 shares of the health services provider’s stock after buying an additional 9,988 shares during the period. California State Teachers Retirement System’s holdings in Maximus were worth $4,047,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors have also recently made changes to their positions in the company. Seizert Capital Partners LLC bought a new position in Maximus in the fourth quarter worth approximately $1,863,000. Ruffer LLP acquired a new stake in Maximus during the fourth quarter worth about $6,951,000. UBS Group AG grew its holdings in Maximus by 76.8% in the fourth quarter. UBS Group AG now owns 610,354 shares of the health services provider’s stock valued at $52,686,000 after purchasing an additional 265,095 shares during the period. Dimensional Fund Advisors LP raised its holdings in shares of Maximus by 7.2% during the first quarter. Dimensional Fund Advisors LP now owns 2,107,278 shares of the health services provider’s stock valued at $135,084,000 after acquiring an additional 141,362 shares during the last quarter. Finally, Comerica Bank lifted its stake in Maximus by 124.4% in the 4th quarter. Comerica Bank now owns 61,284 shares of the health services provider’s stock worth $5,290,000 after purchasing an additional 33,973 shares in the last quarter. Institutional investors own 97.21% of the company’s stock.
Key Maximus News
Here are the key news stories impacting Maximus this week:
- Positive Sentiment: Fiscal Q3 adjusted earnings were $2.22 per share, ahead of analyst estimates of approximately $2.20–$2.21 and up from $2.16 a year earlier. Higher margins also supported the quarter’s bottom-line performance. Maximus Q3 Earnings Beat Estimates, Increase Year Over Year
- Positive Sentiment: The earnings beat, year-over-year EPS growth and stronger margins indicate that Maximus is maintaining profitability even as sales soften. Maximus Q3 Earnings Beat Estimates
- Neutral Sentiment: Management’s fiscal Q3 earnings call focused on the quarterly performance and updated outlook, providing investors with additional context on operating trends and the company’s expectations for the remainder of fiscal 2026. Maximus Q3 2026 Earnings Call Transcript
- Negative Sentiment: Revenue was $1.28 billion, below the $1.33 billion consensus estimate and down 5.1% year over year. The shortfall suggests softer demand or project timing is limiting growth. Maximus Fiscal Q3 Earnings Snapshot
- Negative Sentiment: Maximus reduced fiscal 2026 EPS guidance to $7.90–$8.20, below the consensus estimate of $8.43. Revenue guidance of $5.2–$5.4 billion remains broadly in line with expectations at the midpoint, but the lower profit outlook is a key overhang for MMS. Updated Maximus Fiscal 2026 Guidance
Maximus Stock Up 1.5%
Maximus (NYSE:MMS – Get Free Report) last issued its earnings results on Thursday, August 6th. The health services provider reported $2.22 earnings per share for the quarter, beating analysts’ consensus estimates of $2.21 by $0.01. The firm had revenue of $1.28 billion for the quarter, compared to analysts’ expectations of $1.33 billion. Maximus had a return on equity of 24.91% and a net margin of 7.07%.The firm’s revenue for the quarter was down 5.1% compared to the same quarter last year. During the same quarter last year, the firm earned $2.16 earnings per share. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. On average, research analysts expect that Maximus, Inc. will post 8.05 earnings per share for the current year.
Maximus Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Stockholders of record on Friday, August 14th will be issued a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date is Friday, August 14th. Maximus’s payout ratio is 19.76%.
Analysts Set New Price Targets
MMS has been the subject of a number of recent analyst reports. Weiss Ratings cut shares of Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research report on Wednesday, May 20th. Wall Street Zen cut Maximus from a “buy” rating to a “hold” rating in a research note on Saturday. Finally, Zacks Research cut shares of Maximus from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 27th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock has a consensus rating of “Hold”.
Read Our Latest Research Report on Maximus
Maximus Company Profile
Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
Featured Articles
- Five stocks we like better than Maximus
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
